Navigation Links
NeoStem Obtains Exclusive License to Innovative Stem Cell Procedure Treating Musculoskeletal Diseases
Date:5/11/2009

License Strengthens NeoStem's Portfolio of Regenerative Treatments

NEW YORK, May 11, /PRNewswire-FirstCall/ -- NeoStem, Inc. (NYSE Amex: NBS), which is pioneering the pre-disease collection, processing and long-term storage of adult stem cells for future medical need, announced today it has signed an exclusive royalty-bearing license agreement for the Asia territory to use an innovative process that rapidly grows a patient's own adult stem cells to treat a variety of musculoskeletal diseases.

The licensed procedure has been developed by Regenerative Sciences, LLC, a Colorado-based company focused on developing a medical procedure for the treatment of chronic orthopedic conditions. Known under the name Regenexx(TM), the innovative outpatient procedure takes stem cells from an individual's bone marrow, isolates mesenchymal stem cells (which can grow into bone, tendon, muscle, ligament and cartilage), cultures them in a solution containing unique elements from the individual's own blood, and generates millions of stem cells over two to three weeks. These cells are then re-injected into the person's joints or bones in an office procedure to assist in tissue healing and restoration of bone and cartilage. The Regenexx Procedure has helped many patients avoid more risky and costly surgical intervention.

Additionally, Regenerative Sciences, through its founder and CEO, Christopher Centeno, M.D., will serve as a consultant to NeoStem, Inc. in the area of stem cell therapy in orthopedics. Dr. Centeno is an international expert in musculoskeletal, spinal and neurological injury. Dr. Centeno will continue to assist NeoStem in using mesenchymal stem cell isolation and transplantation methods abroad in the lab and clinical setting. He will also train NeoStem personnel in Colorado in mesenchymal stem cell isolation, prepar
'/>"/>

SOURCE NeoStem, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. NeoStem Obtains Exclusive Worldwide License for Innovative Stem Cell Technology and Applications to Heal Chronic Wounds
2. NeoStem, Inc. Announces Agreement With Progenitor Cell Therapy, LLC
3. NeoStem Completes $11 Million Private Placement Financing to Support Expansion Activities in China, Further Development of NeoStems VSEL Technology and Advancement of Medical Tourism Initiatives
4. NeoStem Expands Stem Cell Collection Center Network Into New Jersey Led by Leading Plastic Surgeon and Anti-Aging Authority
5. NeoStem Obtains Exclusive Worldwide License to Innovative Stem Cell Technology and Applications for Anti-Aging Skin Rejuvenation Therapies
6. NeoStem Receives Notice of Noncompliance from NYSE Alternext US
7. NeoStems New York City Adult Stem Cell Collection Center Has Opened and Begun Collections
8. NeoStem Completes $500,000 Private Placement With Strategic Investor
9. NeoStem, Inc. to Enter the Regenerative Medicine Market in Asia
10. NeoStem Secures $250,000 in an Above Market Financing and Expands Its Relationship With New England Cryogenic Center, Inc.
11. Suzanne Somers, Renowned Author, Medical Advocate, and Official Spokesperson for NeoStem, Inc., Inspires the Audience on The Ellen Degeneres Show

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)..., , SHANGHAI, Nov. 30 /PRNewswire... pharmaceutical, biotechnology, and medical-device... operations in China and the United States,announ...nology Fast 50 China,2009 list for the fifth conse...owing companies in China,s technology, media, and ...
(Date:11/27/2009)..., , DURHAM, N.C., Nov. 27 /PRNewswir...rk, will initiate water-soluble carbon nanotube-ba...a. The water-soluble carbon nanotubes, which have ...jugation with cancer drugs, was developed in partn...The conjugated carbon nanotubes serves as a drug d...
(Date:11/25/2009)..., , BOSTON, Nov. 25 ...e H1N1 virus, genomic data from the 1918 pandemic ...the current H1N1 pandemic, today issued its latest...hows that the lethality of the H1N1 ("Swine Flu") ...during the virus,s current outbreak in the spring ...
(Date:11/25/2009)..., , NEW YORK, Nov. 25 /PRNewswire/ -...earch report is available in its catalogue: ,, ...o 2013 ,, http://www.reportlinker.com/p016550...to-2013.html ,, Brazil Bioethanol Market Analy...e report provides detailed analysis and forecasts ...
Breaking Biology Technology:WuXi PharmaTech Named in Deloitte Technology Fast 50 China 2009 List for the Fifth Consecutive Year 2North Carolina Based Cromoz Inc. Launches Carbon Nanotechnology for Target Drug Delivery System in Cancer Treatment in Hyderabad, India 2Biological H1N1 Vaccines: Too Little, Too Late 2Biological H1N1 Vaccines: Too Little, Too Late 3Biological H1N1 Vaccines: Too Little, Too Late 4Biological H1N1 Vaccines: Too Little, Too Late 5Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 2Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 3Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 4Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 5Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 6Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 7Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 8Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 9Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 10
..., Dec. 20 Conatus Pharmaceuticals Inc. today,anno...vel drug candidate,for the treatment of liver dise...ion in patients who have failed the approved stand... drug candidate, CTS-1027, is being studied as,a t...resulting from,infection by HCV. CTS-1027 inhibits...
... Calif., Dec. 20 Ardea Biosciences,Inc. (Nasdaq: ...velopment of,small-molecule therapeutics for the t...y diseases, today announced that it has entered in...stitutional investors to raise,approximately $40 m... 3.0,million newly issued shares of its common sto...
..., Dec. 20 /Xinhua-PRNewswire-FirstCall/ -- China T...TDC, "the Company" or "CTDC"), a,provider of clean...ing on,solar energy business in China, today annou...ategic plan to focus the Company,s management and,...olar energy., On December 18, 2007, the Company d...
Other Biology Technology:Conatus Pharmaceuticals Initiates a Phase 2 Clinical Trial for the Treatment of Hepatitis 2Ardea Biosciences Announces $40 Million Private Placement 2Ardea Biosciences Announces $40 Million Private Placement 3CTDC Announces the Disposal of Non-core Business 2
(Date:11/30/2009)...erimental Biology are pleased to announce that Dr...e Scientifique (CNRS) in the Universit de Nice-Sop...utstanding Paper Prize. ,The prize is awarded in r...tended to encourage young scientists, says Hans H... ,we truly appreciate when authors submit their ve...
(Date:11/30/2009)... rise scientists are presented with the complex ch...dapt. In a paper published in Insect Conservation...d Dr Miguel Rodriguez assess this challenge. , T....6˚C has already affected the Earth,s biota a...volutionary biologists is to predict how biologica...
(Date:11/30/2009)...seeing your extended family over the holidays was ...in the December 2009 print issue of the Journal o...hows that you might be right. Here,s the good news...ly new treatments that help keep autoimmune diseas.... That,s because researchers from the University o...
Breaking Biology News(10 mins):French scientist wins the Journal of Experimental Biology Outstanding Paper Prize 2009 2French scientist wins the Journal of Experimental Biology Outstanding Paper Prize 2009 3French scientist wins the Journal of Experimental Biology Outstanding Paper Prize 2009 4How can scientists measure evolutionary responses to climate change? 2Seeing family for the holidays? Scientists discover how the stress might kill you 2Association of Retired Xerox Employees Initiate Legal Proceedings Against Xerox Corporation 58522 1Association of Retired Xerox Employees Initiate Legal Proceedings Against Xerox Corporation 58522 2Incept BioSystems Initiates First Human Clinical Trial of its SMART Embryo Culture System for In Vitro Fertilization 28IVF 29 5098 1Incept BioSystems Initiates First Human Clinical Trial of its SMART Embryo Culture System for In Vitro Fertilization 28IVF 29 5098 2Incept BioSystems Initiates First Human Clinical Trial of its SMART Embryo Culture System for In Vitro Fertilization 28IVF 29 5098 3Orexigen 28R 29 Therapeutics Phase 2b Trial for Empatic 28TM 29 Meets Primary Efficacy Endpoint Demonstrating Significantly Greater Weight Loss Versus 58518 1Orexigen 28R 29 Therapeutics Phase 2b Trial for Empatic 28TM 29 Meets Primary Efficacy Endpoint Demonstrating Significantly Greater Weight Loss Versus 58518 2Orexigen 28R 29 Therapeutics Phase 2b Trial for Empatic 28TM 29 Meets Primary Efficacy Endpoint Demonstrating Significantly Greater Weight Loss Versus 58518 3Orexigen 28R 29 Therapeutics Phase 2b Trial for Empatic 28TM 29 Meets Primary Efficacy Endpoint Demonstrating Significantly Greater Weight Loss Versus 58518 4Orexigen 28R 29 Therapeutics Phase 2b Trial for Empatic 28TM 29 Meets Primary Efficacy Endpoint Demonstrating Significantly Greater Weight Loss Versus 58518 5Orexigen 28R 29 Therapeutics Phase 2b Trial for Empatic 28TM 29 Meets Primary Efficacy Endpoint Demonstrating Significantly Greater Weight Loss Versus 58518 6
...en oxides produced by huge fires and fossil fuel c...They are the primary ingredients in ground-level o...tation. , But new research led by a University of ...me regions, nitrogen oxides emitted by the soil ar...tantially larger role in seasonal air pollution th...
...circulates in our bodies through a complex network...his network is, however, of major importance for t...ur body. Researchers from the Flanders Interuniver...ith the Catholic University of Leuven, are the fir...th the help of tadpoles. This accelerates research...
...ie Mellon CyLab computer scientist Yang Cai is wor...e (ESTO), the Goddard Space Flight Center (GSFC) a...tion (NOAA) to develop new software for detecting ...aters. , "We are developing software that will mon...lies for public health," said Cai, who noted other...
Other Biology News:Study uncovers dirty little secret: Soil emissions are much-bigger-than-expected component of air pollution 2Study uncovers dirty little secret: Soil emissions are much-bigger-than-expected component of air pollution 3Tadpole soon to help in the fight against cancer and lymphedema 2Tadpole soon to help in the fight against cancer and lymphedema 3Carnegie Mellon cyLab researchers work to develop new red tide monitoring 2
Rabbit Anti-Human OLFM1 Polyclonal Antibody, Unconjugated from Proteintech Group, Inc.
...me isolated from Pseudomonas atlantica. Gelzyme en...producing carbohydrate molecules that can no longe...ot interfere with subsequent DNA manipulation. DNA...riction endonuclease digestions ligations and tran...
... contains the cellular components necessary for pr...tiation, elongation and termination factors) but h...reated Lysate is used primarily for the isolation ...ndogenous globin mRNA. Untreated Lysate is prepare...
Axl, phospho ELISA development Kit, DuoSet IC Economy Pack from R&D Systems
Biology Products: